KR102086389B1 - 트리아졸 화합물의 제조 방법 - Google Patents

트리아졸 화합물의 제조 방법 Download PDF

Info

Publication number
KR102086389B1
KR102086389B1 KR1020147033989A KR20147033989A KR102086389B1 KR 102086389 B1 KR102086389 B1 KR 102086389B1 KR 1020147033989 A KR1020147033989 A KR 1020147033989A KR 20147033989 A KR20147033989 A KR 20147033989A KR 102086389 B1 KR102086389 B1 KR 102086389B1
Authority
KR
South Korea
Prior art keywords
formula
compound
sodium
mixture
triazol
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
KR1020147033989A
Other languages
English (en)
Korean (ko)
Other versions
KR20150018534A (ko
Inventor
한스-크리스챤 밀리트제르
조한네스 에게르트
Original Assignee
바이엘 파마 악티엔게젤샤프트
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=48325714&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=KR102086389(B1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by 바이엘 파마 악티엔게젤샤프트 filed Critical 바이엘 파마 악티엔게젤샤프트
Publication of KR20150018534A publication Critical patent/KR20150018534A/ko
Application granted granted Critical
Publication of KR102086389B1 publication Critical patent/KR102086389B1/ko
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/14Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/32One oxygen, sulfur or nitrogen atom
    • C07D239/42One nitrogen atom
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D249/00Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/041,2,3-Triazoles; Hydrogenated 1,2,3-triazoles

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
KR1020147033989A 2012-05-08 2013-05-06 트리아졸 화합물의 제조 방법 Active KR102086389B1 (ko)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP12167152.3 2012-05-08
EP12167152 2012-05-08
PCT/EP2013/059418 WO2013167552A1 (de) 2012-05-08 2013-05-06 Verfahren zur herstellung von triazol-verbindungen

Publications (2)

Publication Number Publication Date
KR20150018534A KR20150018534A (ko) 2015-02-23
KR102086389B1 true KR102086389B1 (ko) 2020-03-09

Family

ID=48325714

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020147033989A Active KR102086389B1 (ko) 2012-05-08 2013-05-06 트리아졸 화합물의 제조 방법

Country Status (35)

Country Link
US (1) US10301289B2 (https=)
EP (1) EP2847183B1 (https=)
JP (1) JP6149104B2 (https=)
KR (1) KR102086389B1 (https=)
CN (1) CN104411704B (https=)
AP (1) AP2014008089A0 (https=)
AU (1) AU2013258107B2 (https=)
BR (1) BR112014027564B1 (https=)
CA (1) CA2872726C (https=)
CL (2) CL2014003003A1 (https=)
CO (1) CO7121324A2 (https=)
CR (1) CR20140514A (https=)
CU (1) CU20140128A7 (https=)
DK (1) DK2847183T3 (https=)
DO (1) DOP2014000254A (https=)
EA (1) EA027804B1 (https=)
ES (1) ES2641205T3 (https=)
HR (1) HRP20171321T1 (https=)
HU (1) HUE034430T2 (https=)
IL (1) IL235441A (https=)
LT (1) LT2847183T (https=)
MX (1) MX350519B (https=)
MY (1) MY184577A (https=)
NZ (1) NZ701661A (https=)
PE (1) PE20142453A1 (https=)
PH (1) PH12014502482A1 (https=)
PL (1) PL2847183T3 (https=)
PT (1) PT2847183T (https=)
RS (1) RS56255B1 (https=)
SG (2) SG10201609319YA (https=)
SI (1) SI2847183T1 (https=)
TN (1) TN2014000469A1 (https=)
UA (1) UA116349C2 (https=)
WO (1) WO2013167552A1 (https=)
ZA (1) ZA201408571B (https=)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2639716B2 (ja) 1988-12-14 1997-08-13 横浜ゴム株式会社 タイヤ成形装置に於けるグリーンタイヤの搬送装置
JOP20170103A1 (ar) * 2016-05-03 2017-11-03 Bayer Pharma AG عملية لتحضير مشتقات 1-فنيل-1، 2، 4-تريازول مستبدلة بـ 5-هيدروكسي ألكيل
CN108084099B (zh) * 2017-12-20 2019-01-29 天驰药业有限公司 一种1,2,3-三氮唑化合物的合成方法
US10702525B1 (en) 2019-09-04 2020-07-07 United Arab Emirates University Pyrimidine derivatives as anti-diabetic agents
EP3888684A1 (en) 2020-03-31 2021-10-06 Bayer Animal Health GmbH Composition having improved voluntary acceptance
JP7710897B2 (ja) * 2021-06-01 2025-07-22 三菱ガス化学ネクスト株式会社 1-アルキル-5-ヒドロキシピラゾールの製造方法
CN114264752B (zh) * 2021-12-29 2023-08-15 北京金城泰尔制药有限公司 溴乙酸甲酯的检测方法

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK135184A (da) 1983-03-03 1984-10-10 Riker Laboratories Inc Triazol(4,3-c)- og triazol(1,5-c)pyrimidiner
US4572910A (en) * 1983-03-03 1986-02-25 Riker Laboratories, Inc. Triazolo[1,5-c]pyrimidines substituted by nitrogen-containing heterocyclic rings
US4752910A (en) 1984-10-30 1988-06-21 Prime Computer, Inc. Method and apparatus for continuous after-imaging
UY27813A1 (es) * 2002-05-31 2003-12-31 Smithkline Beecham Corp Inhibidores de la peptido-desformilasa
CL2003002353A1 (es) 2002-11-15 2005-02-04 Vertex Pharma Compuestos derivados de diaminotriazoles, inhibidores d ela proteina quinasa; composicion farmaceutica; procedimiento de preparacion; y su uso del compuesto en el tratamiento de enfermedades de desordenes alergicos, proliferacion, autoinmunes, condic
WO2005044785A1 (en) * 2003-10-30 2005-05-19 Merck & Co., Inc. Aralkyl amines as cannabinoid receptor modulators
US7745630B2 (en) 2003-12-22 2010-06-29 Justin Stephen Bryans Triazolyl piperidine arginine vasopressin receptor modulators
DE102008020113A1 (de) 2008-04-23 2009-10-29 Bayer Schering Pharma Aktiengesellschaft Substituierte Dihydropyrazolone und ihre Verwendung
EP1877399A1 (en) 2005-04-26 2008-01-16 Pfizer Limited Triazole derivatives as vasopressin antagonists
CA2608718A1 (en) 2005-05-18 2006-11-23 Pfizer Limited 1, 2, 4-triazole derivatives as vasopressin antagonists
DE102006050516A1 (de) * 2006-10-26 2008-04-30 Bayer Healthcare Ag Substituierte Dihydropyrazolone und ihre Verwendung
DE102010041236A1 (de) * 2010-09-23 2012-03-29 Osram Ag Optoelektronisches Halbleiterbauelement
DE102010044131A1 (de) * 2010-11-18 2012-05-24 Bayer Schering Pharma Aktiengesellschaft Substituiertes Natrium-1H-pyrazol-5-olat

Also Published As

Publication number Publication date
JP2015516403A (ja) 2015-06-11
EP2847183B1 (de) 2017-06-21
CO7121324A2 (es) 2014-11-20
CR20140514A (es) 2014-12-02
LT2847183T (lt) 2017-09-25
CA2872726A1 (en) 2013-11-14
KR20150018534A (ko) 2015-02-23
SG10201609319YA (en) 2016-12-29
TN2014000469A1 (en) 2016-03-30
EA027804B1 (ru) 2017-09-29
WO2013167552A1 (de) 2013-11-14
CL2014003003A1 (es) 2015-02-13
IL235441A (en) 2017-09-28
ZA201408571B (en) 2016-03-30
HK1208027A1 (en) 2016-02-19
BR112014027564A2 (https=) 2017-08-22
PL2847183T3 (pl) 2017-11-30
JP6149104B2 (ja) 2017-06-14
PE20142453A1 (es) 2015-01-17
UA116349C2 (uk) 2018-03-12
RS56255B1 (sr) 2017-11-30
HRP20171321T1 (hr) 2017-10-20
MX350519B (es) 2017-09-08
US20150087827A1 (en) 2015-03-26
SI2847183T1 (sl) 2017-10-30
DK2847183T3 (en) 2017-10-02
NZ701661A (en) 2016-08-26
PH12014502482A1 (en) 2015-01-12
CN104411704A (zh) 2015-03-11
SG11201407043PA (en) 2014-12-30
AP2014008089A0 (en) 2014-11-30
MY184577A (en) 2021-04-06
CL2016001165A1 (es) 2016-12-02
HUE034430T2 (en) 2018-02-28
AU2013258107A1 (en) 2014-11-27
MX2014013448A (es) 2014-12-08
ES2641205T3 (es) 2017-11-08
US10301289B2 (en) 2019-05-28
PT2847183T (pt) 2017-10-02
AU2013258107B2 (en) 2017-06-22
DOP2014000254A (es) 2016-01-31
EP2847183A1 (de) 2015-03-18
BR112014027564B1 (pt) 2022-05-03
CN104411704B (zh) 2017-12-22
EA201492032A1 (ru) 2015-04-30
CA2872726C (en) 2020-07-07
CU20140128A7 (es) 2015-03-30

Similar Documents

Publication Publication Date Title
KR102086389B1 (ko) 트리아졸 화합물의 제조 방법
HU230577B1 (hu) Eljárás 2-etoxi-1-((2'-(5-oxo-4,5-dihidro-1,2,4-oxadiazol-3-il)-bifenil-4-il)-metil)-1H-benzol[d]imidazol7-karboxilátok előállítására és ezek átalakítása azilsartanná
JP2020518573A (ja) 2−([1,2,3]トリアゾール−2−イル)−安息香酸誘導体の製造
KR102458638B1 (ko) 메데토미딘의 합성에서 유용한 3-아릴부탄알과 같은 화합물의 제조 방법
US6664401B2 (en) Process for preparing isocoumarins
Karandeeva et al. Synthesis of spiro [chromane-2, 4'-pyrimidines] by condensation of 6-styryldihydropyrimidin-2-ones with resorcinols
Shuangxia et al. An efficient and green synthetic route to losartan
Vraničar et al. Synthesis and transformations of a pyrazole containing α, β-didehydro-α-amino acid derivatives
BR112012029363B1 (pt) Processo para preparar 1-alquil-3-difluorometil-5 -hidroxipirazóis
HK1208027B (en) Method for the preparation of triazole compounds
JP4541143B2 (ja) キノリン誘導体の製造方法
JP2984848B2 (ja) N―アルキルピラゾール誘導体の製法
JP3855686B2 (ja) 3,3−ジアルコキシ−2−ヒドロキシイミノ誘導体及びその製造法
WO2020234379A1 (en) Processes and intermediates for preparing a btk inhibitor
US20040116732A1 (en) 3,3-Dialkoxy-2-hydroxyiminopropionitriles, process for preparation thereof and process of preparing 5-amino-4-nitrosopyrazoles or salts thereof by the use of the same
JP2002363171A (ja) 4−置換−3−アミノイソオキサゾール誘導体の製法
JP2008540351A (ja) 5−アルキルチオアルキルアミノ−1−フェニル−ピラゾールを製造する方法
MX2008009034A (en) Process for preparing substituted biphenyls
JP2001058983A (ja) 1−置換5−ヒドロキシ−イミダゾリン−2,4−ジオン類及び1−置換5−アルコキシ−イミダゾリン−2,4−ジオン類の製造方法
JPH0114907B2 (https=)

Legal Events

Date Code Title Description
PA0105 International application

St.27 status event code: A-0-1-A10-A15-nap-PA0105

PG1501 Laying open of application

St.27 status event code: A-1-1-Q10-Q12-nap-PG1501

A201 Request for examination
P11-X000 Amendment of application requested

St.27 status event code: A-2-2-P10-P11-nap-X000

P13-X000 Application amended

St.27 status event code: A-2-2-P10-P13-nap-X000

PA0201 Request for examination

St.27 status event code: A-1-2-D10-D11-exm-PA0201

R17-X000 Change to representative recorded

St.27 status event code: A-3-3-R10-R17-oth-X000

E902 Notification of reason for refusal
PE0902 Notice of grounds for rejection

St.27 status event code: A-1-2-D10-D21-exm-PE0902

E13-X000 Pre-grant limitation requested

St.27 status event code: A-2-3-E10-E13-lim-X000

P11-X000 Amendment of application requested

St.27 status event code: A-2-2-P10-P11-nap-X000

P13-X000 Application amended

St.27 status event code: A-2-2-P10-P13-nap-X000

R17-X000 Change to representative recorded

St.27 status event code: A-3-3-R10-R17-oth-X000

R17-X000 Change to representative recorded

St.27 status event code: A-3-3-R10-R17-oth-X000

E701 Decision to grant or registration of patent right
PE0701 Decision of registration

St.27 status event code: A-1-2-D10-D22-exm-PE0701

GRNT Written decision to grant
PR0701 Registration of establishment

St.27 status event code: A-2-4-F10-F11-exm-PR0701

PR1002 Payment of registration fee

St.27 status event code: A-2-2-U10-U12-oth-PR1002

Fee payment year number: 1

PG1601 Publication of registration

St.27 status event code: A-4-4-Q10-Q13-nap-PG1601

PR1001 Payment of annual fee

St.27 status event code: A-4-4-U10-U11-oth-PR1001

Fee payment year number: 4

PR1001 Payment of annual fee

St.27 status event code: A-4-4-U10-U11-oth-PR1001

Fee payment year number: 5

PR1001 Payment of annual fee

St.27 status event code: A-4-4-U10-U11-oth-PR1001

Fee payment year number: 6

PR1001 Payment of annual fee

St.27 status event code: A-4-4-U10-U11-oth-PR1001

Fee payment year number: 7

U11 Full renewal or maintenance fee paid

Free format text: ST27 STATUS EVENT CODE: A-4-4-U10-U11-OTH-PR1001 (AS PROVIDED BY THE NATIONAL OFFICE)

Year of fee payment: 7